Certara (NASDAQ:CERT) Sees Unusually-High Trading Volume – Here’s What Happened

Shares of Certara, Inc. (NASDAQ:CERT) saw an uptick in trading volume on Thursday . 1,332,401 shares traded hands during mid-day trading, an increase of 77% from the previous session’s volume of 750,817 shares.The stock last traded at $11.48 and had previously closed at $11.22.

Analyst Ratings Changes

A number of analysts recently weighed in on CERT shares. UBS Group upgraded Certara from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a report on Friday, September 27th. KeyCorp cut their price objective on Certara from $23.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. JMP Securities reissued a “market perform” rating on shares of Certara in a research report on Wednesday, July 10th. Robert W. Baird dropped their price target on shares of Certara from $19.00 to $18.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, Barclays decreased their price objective on shares of Certara from $16.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Certara presently has a consensus rating of “Hold” and a consensus price target of $17.08.

Certara Price Performance

The stock has a market capitalization of $1.84 billion, a P/E ratio of -29.26, a PEG ratio of 5.40 and a beta of 1.49. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.61 and a current ratio of 2.61. The business has a fifty day simple moving average of $11.62 and a 200-day simple moving average of $14.41.

Certara (NASDAQ:CERT) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03). Certara had a negative net margin of 21.64% and a positive return on equity of 3.03%. The business had revenue of $93.31 million during the quarter, compared to analyst estimates of $96.01 million. During the same period in the previous year, the business posted $0.10 EPS. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. Sell-side analysts expect that Certara, Inc. will post 0.27 earnings per share for the current fiscal year.

Insider Activity at Certara

In other news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $11.29, for a total value of $578,318.96. Following the completion of the sale, the insider now directly owns 99,704 shares of the company’s stock, valued at $1,125,658.16. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Certara news, insider Patrick F. Smith sold 5,409 shares of the company’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $11.03, for a total value of $59,661.27. Following the completion of the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $11.29, for a total transaction of $578,318.96. Following the completion of the sale, the insider now owns 99,704 shares of the company’s stock, valued at approximately $1,125,658.16. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 2.39% of the stock is owned by insiders.

Hedge Funds Weigh In On Certara

A number of hedge funds and other institutional investors have recently modified their holdings of the business. First Hawaiian Bank purchased a new position in Certara in the first quarter worth $618,000. Wasatch Advisors LP boosted its holdings in shares of Certara by 23.4% in the 1st quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock worth $88,056,000 after buying an additional 932,598 shares during the last quarter. Capstone Investment Advisors LLC bought a new position in Certara during the first quarter valued at about $245,000. GSA Capital Partners LLP purchased a new stake in Certara during the first quarter worth about $571,000. Finally, Geneva Capital Management LLC raised its position in Certara by 15.1% in the first quarter. Geneva Capital Management LLC now owns 4,404,199 shares of the company’s stock worth $78,747,000 after acquiring an additional 579,349 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.